Organism name | Haliclona oculata |
---|---|
Genus | |
Family | |
Kingdom |
Linked NCBI taxonomy name | Haliclona oculata |
---|---|
Linked NCBI taxonomy ID | 6058 |
Linked level | species |
Family in NCBI taxonomy | Chalinidae |
---|---|
ID | 6056 |
Kingdom (Superkingdom) in NCBI taxonomy | Metazoa |
---|---|
ID | 33208 |
Plant class | |
---|---|
ID |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
---|---|---|---|---|---|---|---|---|
C00041598
![]() |
Indole-3-methanol
|
CHEMBL155625
|
C016517
|
7 / 1 / 1 | 50 / 7 | No. 710 | No. 4 |
![]() |
C00041260
![]() |
2-Ethoxycarbonyl-24-ethyl-2beta-hydroxy-A-nor-cholesta-5-en-4-one
/ (-)-2-Ethoxycarbonyl-24-ethyl-2beta-hydroxy-A-nor-cholesta-5-en-4-one |
No. 2236 |
![]() |
|||||
C00000113
![]() |
Indole-3-carboxylic acid
|
CHEMBL387527
|
C012382
|
1 / 3 / 4 | No. 3632 |
![]() |
||
C00000112
![]() |
Indole-3-carboxaldehyde
/ 1H-Indole-3-carboxaldehyde |
CHEMBL147741
|
C012381
|
2 / 1 / 1 | No. 4314 |
![]() |
||
C00041286
![]() |
6-Hydroxyindole-3-carboxaldehyde
|
No. 6145 |
![]() |
|||||
C00041709
![]() |
Oculatol
/ (+)-Oculatol |
No. 6342 |
![]() |
|||||
C00041710
![]() |
Oculatolide
/ (+)-Oculatolide |
No. 7250 |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Enzyme | C00041598 | 0 / 0 |
P12268 | Inosine-5'-monophosphate dehydrogenase 2 | Oxidoreductase | C00000112 | 0 / 0 |
O75496 | Geminin | Unclassified protein | C00041598 | 0 / 0 |
P10145 | Interleukin-8 | Secreted protein | C00041598 | 0 / 0 |
P51449 | Nuclear receptor ROR-gamma | Nuclear hormone receptor subfamily 1 group F member 3 | C00041598 | 0 / 0 |
P00374 | Dihydrofolate reductase | Oxidoreductase | C00000112 | 1 / 1 |
P03372 | Estrogen receptor | NR3A1 | C00041598 | 1 / 1 |
Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | C00041598 | 0 / 0 |
P10275 | Androgen receptor | NR3C4 | C00000113 | 3 / 4 |
Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | C00041598 | 0 / 0 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
5243 | ABCB1, ABC20, CD243, CLCS, GP170, MDR1, P-GP, PGY1 | ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) |
C00041598
|
9429 | ABCG2, ABC15, ABCP, BCRP, BCRP1, BMDP, CD338, CDw338, EST157481, GOUT1, MRX, MXR, MXR1, UAQTL1 | ATP-binding cassette, sub-family G (WHITE), member 2 |
C00041598
|
196 | AHR, bHLHe76 | aryl hydrocarbon receptor |
C00041598
|
367 | AR, AIS, DHTR, HUMARA, HYSP1, KD, NR3C4, SBMA, SMAX1, TFM | androgen receptor |
C00041598
|
581 | BAX, BCL2L4 | BCL2-associated X protein |
C00041598
|
596 | BCL2, Bcl-2, PPP1R50 | B-cell CLL/lymphoma 2 |
C00041598
|
597 | BCL2A1, ACC-1, ACC-2, BCL2L5, BFL1, GRS, HBPA1 | BCL2-related protein A1 |
C00041598
|
598 | BCL2L1, BCL-XL/S, BCL2L, BCLX, BCLXL, BCLXS, Bcl-X, PPP1R52, bcl-xL, bcl-xS | BCL2-like 1 |
C00041598
|
329 | BIRC2, API1, HIAP2, Hiap-2, MIHB, RNF48, c-IAP1, cIAP1 | baculoviral IAP repeat containing 2 |
C00041598
|
330 | BIRC3, AIP1, API2, CIAP2, HAIP1, HIAP1, MALT2, MIHC, RNF49, c-IAP2 | baculoviral IAP repeat containing 3 |
C00041598
|
332 | BIRC5, API4, EPR-1 | baculoviral IAP repeat containing 5 |
C00041598
|
672 | BRCA1, BRCAI, BRCC1, BROVCA1, IRIS, PNCA4, PPP1R53, PSCP, RNF53 | breast cancer 1, early onset |
C00041598
|
675 | BRCA2, BRCC2, BROVCA2, FACD, FAD, FAD1, FANCB, FANCD, FANCD1, GLM3, PNCA2 | breast cancer 2, early onset |
C00041598
|
836 | CASP3, CPP32, CPP32B, SCA-1 | caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) |
C00041598
|
842 | CASP9, APAF-3, APAF3, ICE-LAP6, MCH6, PPP1R56 | caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) |
C00041598
|
595 | CCND1, BCL1, D11S287E, PRAD1, U21B31 | cyclin D1 |
C00041598
|
898 | CCNE1, CCNE | cyclin E1 |
C00041598
|
1017 | CDK2, p33(CDK2) | cyclin-dependent kinase 2 (EC:2.7.11.22) |
C00041598
|
1019 | CDK4, CMM3, PSK-J3 | cyclin-dependent kinase 4 (EC:2.7.11.22) |
C00041598
|
1021 | CDK6, PLSTIRE | cyclin-dependent kinase 6 (EC:2.7.11.22) |
C00041598
|
1026 | CDKN1A, CAP20, CDKN1, CIP1, MDA-6, P21, SDI1, WAF1, p21CIP1 | cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
C00041598
|
1027 | CDKN1B, CDKN4, KIP1, MEN1B, MEN4, P27KIP1 | cyclin-dependent kinase inhibitor 1B (p27, Kip1) |
C00041598
|
1030 | CDKN2B, CDK4I, INK4B, MTS2, P15, TP15, p15INK4b | cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) |
C00041598
|
8837 | CFLAR, CASH, CASP8AP1, CLARP, Casper, FLAME, FLAME-1, FLAME1, FLIP, I-FLICE, MRIT, c-FLIP, c-FLIPL, c-FLIPR, c-FLIPS | CASP8 and FADD-like apoptosis regulator |
C00041598
|
1147 | CHUK, IKBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16 | conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10) |
C00041598
|
1509 | CTSD, CLN10, CPSD | cathepsin D (EC:3.4.23.5) |
C00041598
|
54205 | CYCS, CYC, HCS, THC4 | cytochrome c, somatic |
C00041598
|
1543 | CYP1A1, AHH, AHRR, CP11, CYP1, P1-450, P450-C, P450DX | cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) |
C00041598
|
1545 | CYP1B1, CP1B, CYPIB1, GLC3A, P4501B1 | cytochrome P450, family 1, subfamily B, polypeptide 1 (EC:1.14.14.1) |
C00041598
|
1956 | EGFR, ERBB, ERBB1, HER1, PIG61, mENA | epidermal growth factor receptor (EC:2.7.10.1) |
C00041598
|
2099 | ESR1, ER, ESR, ESRA, ESTRR, Era, NR3A1 | estrogen receptor 1 |
C00041598
|
9518 | GDF15, GDF-15, MIC-1, MIC1, NAG-1, PDF, PLAB, PTGFB | growth differentiation factor 15 |
C00041598
|
3551 | IKBKB, IKK-beta, IKK2, IKKB, NFKBIKB | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta (EC:2.7.11.10) |
C00041598
|
3553 | IL1B, IL-1, IL1-BETA, IL1F2 | interleukin 1, beta |
C00041598
|
3569 | IL6, BSF2, HGF, HSF, IFNB2, IL-6 | interleukin 6 (interferon, beta 2) |
C00041598
|
4318 | MMP9, CLG4B, GELB, MANDP2, MMP-9 | matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) |
C00041598
|
4582 | MUC1, CA_15-3, CD227, EMA, H23AG, KL-6, MAM6, MCKD1, MUC-1, MUC-1/SEC, MUC-1/X, MUC1/ZD, PEM, PEMT, PUM | mucin 1, cell surface associated |
C00041598
|
4780 | NFE2L2, NRF2 | nuclear factor, erythroid 2-like 2 |
C00041598
|
4790 | NFKB1, EBP-1, KBF1, NF-kB1, NF-kappa-B, NF-kappaB, NFKB-p105, NFKB-p50, NFkappaB, p105, p50 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
C00041598
|
4792 | NFKBIA, IKBA, MAD-3, NFKBI | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
C00041598
|
142 | PARP1, ADPRT, ADPRT_1, ADPRT1, ARTD1, PARP, PARP-1, PPOL, pADPRT-1 | poly (ADP-ribose) polymerase 1 (EC:2.4.2.30) |
C00041598
|
5328 | PLAU, ATF, BDPLT5, QPD, UPA, URK, u-PA | plasminogen activator, urokinase (EC:3.4.21.73) |
C00041598
|
5743 | PTGS2, COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2, hCox-2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) |
C00041598
|
5970 | RELA, NFKB3, p65 | v-rel avian reticuloendotheliosis viral oncogene homolog A |
C00041598
|
6667 | SP1 | Sp1 transcription factor |
C00041598
|
7031 | TFF1, BCEI, D21S21, HP1.A, HPS2, pNR-2, pS2 | trefoil factor 1 |
C00041598
|
7124 | TNF, DIF, TNF-alpha, TNFA, TNFSF2 | tumor necrosis factor |
C00041598
|
7185 | TRAF1, EBI6, MGC:10353 | TNF receptor-associated factor 1 |
C00041598
|
7431 | VIM, CTRCT30 | vimentin |
C00041598
|
331 | XIAP, API3, BIRC4, IAP-3, ILP1, MIHA, XLP2, hIAP-3, hIAP3 | X-linked inhibitor of apoptosis |
C00041598
|
OMIM | preferred title | UniProt |
---|---|---|
#300068 | Androgen insensitivity syndrome; ais |
P10275
|
#312300 | Androgen insensitivity, partial; pais |
P10275
|
#615363 | Estrogen resistance; estrr |
P03372
|
#613839 | Megaloblastic anemia due to dihydrofolate reductase deficiency |
P00374
|
#313200 | Spinal and bulbar muscular atrophy, x-linked 1; smax1 |
P10275
|
KEGG | name | UniProt |
---|---|---|
H01197 | Dihydrofolate reductase (DHFR) deficiency |
P00374
(related)
|
H00026 | Endometrial Cancer |
P03372
(marker)
|
H00024 | Prostate cancer |
P10275
(related)
|
H00062 | Spinal and bulbar muscular atrophy (SBMA) |
P10275
(related)
|
H00608 | 46,XY disorders of sex development (Disorders in androgen synthesis or action) |
P10275
(related)
|
H00609 | 46,XY disorders of sex development (Other) |
P10275
(related)
|
MESH or OMIM | name |
KNApSAcK
metabolite |
---|---|---|
D001943 | Breast Neoplasms |
C00041598
|
D008064 | Lipidoses |
C00041598
|
D008113 | Liver Neoplasms |
C00041598
|
D008114 | Liver Neoplasms, Experimental |
C00041598
|
D008201 | Lymphangiectasis, Intestinal |
C00041598
|
D011472 | Prostatitis |
C00041598
|
D002583 | Uterine Cervical Neoplasms |
C00041598
|